Desq Long
Sign in

Company

PTC THERAPEUTICS, INC.

PTCT · CIK 0001070081

SEC FORM 4
$652,795.92

PTC THERAPEUTICS, INC. (PTCT)

Sale of 9,624 shares at $67.83 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001288952-26-000012 · filed 2026-09-18 · View filing →

SEC FORM 4
$25,737.20

PTC THERAPEUTICS, INC. (PTCT)

Sale of 376 shares at $68.45 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001288952-26-000012 · filed 2026-09-18 · View filing →

SEC FORM 4
$199,340.52

PTC THERAPEUTICS, INC. (PTCT)

Sale of 2,994 shares at $66.58 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001288952-26-000012 · filed 2026-09-18 · View filing →

SEC FORM 4
$471,854.10

PTC THERAPEUTICS, INC. (PTCT)

Sale of 7,006 shares at $67.35 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001288952-26-000012 · filed 2026-09-18 · View filing →

SEC FORM 4
$673,400.00

PTC THERAPEUTICS, INC. (PTCT)

Sale of 10,000 shares at $67.34 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001288952-26-000008 · filed 2026-09-11 · View filing →

SEC FORM 4
$639,124.12

PTC THERAPEUTICS, INC. (PTCT)

Sale of 9,428 shares at $67.79 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001288952-26-000008 · filed 2026-09-11 · View filing →

SEC FORM 4
$39,279.24

PTC THERAPEUTICS, INC. (PTCT)

Sale of 572 shares at $68.67 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001288952-26-000008 · filed 2026-09-11 · View filing →

SEC FORM 4
$850,729.50

PTC THERAPEUTICS, INC. (PTCT)

Sale of 11,890 shares at $71.55 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001288952-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$44,054.20

PTC THERAPEUTICS, INC. (PTCT)

Sale of 610 shares at $72.22 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001288952-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$500,014.76

PTC THERAPEUTICS, INC. (PTCT)

Sale of 6,874 shares at $72.74 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001288952-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$411,710.68

PTC THERAPEUTICS, INC. (PTCT)

Sale of 5,626 shares at $73.18 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001288952-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$666,676.82

PTC THERAPEUTICS, INC. (PTCT)

Sale of 9,419 shares at $70.78 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001288952-26-000004 · filed 2026-08-21 · View filing →

SEC FORM 4
$171,793.20

PTC THERAPEUTICS, INC. (PTCT)

Sale of 2,390 shares at $71.88 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001288952-26-000004 · filed 2026-08-21 · View filing →

SEC FORM 4
$50,387.72

PTC THERAPEUTICS, INC. (PTCT)

Sale of 691 shares at $72.92 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001288952-26-000004 · filed 2026-08-21 · View filing →

SEC FORM 4
$388,708.10

PTC THERAPEUTICS, INC. (PTCT)

Sale of 5,335 shares at $72.86 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001288952-26-000004 · filed 2026-08-21 · View filing →

SEC FORM 4
$527,845.55

PTC THERAPEUTICS, INC. (PTCT)

Sale of 7,165 shares at $73.67 per share.

Reporting Person SCHMERTZLER MICHAEL · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001288952-26-000004 · filed 2026-08-21 · View filing →

SEC FORM 4
$72,265.97

PTC THERAPEUTICS, INC. (PTCT)

Acquisition (code M) of 2,813 shares at $25.69 per share.

Reporting Person Boulding Mark Elliott · Officer Title EXEC. VP AND CLO · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001578852-26-000022 · filed 2026-08-19 · View filing →

SEC FORM 4
$133,487.16

PTC THERAPEUTICS, INC. (PTCT)

Sale of 1,844 shares at $72.39 per share.

Reporting Person Boulding Mark Elliott · Officer Title EXEC. VP AND CLO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001578852-26-000022 · filed 2026-08-19 · View filing →

SEC FORM 4
$70,640.10

PTC THERAPEUTICS, INC. (PTCT)

Sale of 969 shares at $72.90 per share.

Reporting Person Boulding Mark Elliott · Officer Title EXEC. VP AND CLO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001578852-26-000022 · filed 2026-08-19 · View filing →